Bullet News

Eli Lilly’s quarter was messy. What to do with the stock is more clear-cut  

107261723 1687535077484 gettyimages 1302141489 cailly03 XmIYj6

We’re upgrading our rating on the drugmaker to a buy-equivalent 1.

   

Related Posts

108001062 1719945039163 gettyimages 2126120470 ZEPBOUND PATIENT SHORTAGES MfZJyb

Eli Lilly’s Zepbound and Mounjaro are no longer in shortage. Here’s where their sales still fell short  

108004561 1720707229456 gettyimages 2160946683 20090101240711 99 704452 IaVdmC

Novo Nordisk’s Ozempic and Wegovy now available in the U.S. after shortages, FDA says  

107373019 1707846496466 gettyimages 2001172396 porzycki dailylif240213 npCWA H4ArA2

Starbucks is about to report earnings. Here’s what to expect  

About

View all posts by →

Leave a Reply